The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012-2023).

IF 5.2 3区医学 Q1 IMMUNOLOGY

Vaccines Pub Date : 2024-12-24 DOI:10.3390/vaccines13010006

Ines Aguinaga-Ontoso, Sara Guillen-Aguinaga, Laura Guillen-Aguinaga, Rosa Alas-Brun, Miriam Guillen-Aguinaga, Luc Onambele, Enrique Aguinaga-Ontoso, Esperanza Rayón-Valpuesta, Francisco Guillen-Grima

{"title":"The Impact of COVID-19 on DTP3 Vaccination Coverage in Europe (2012-2023).","authors":"Ines Aguinaga-Ontoso, Sara Guillen-Aguinaga, Laura Guillen-Aguinaga, Rosa Alas-Brun, Miriam Guillen-Aguinaga, Luc Onambele, Enrique Aguinaga-Ontoso, Esperanza Rayón-Valpuesta, Francisco Guillen-Grima","doi":"10.3390/vaccines13010006","DOIUrl":null,"url":null,"abstract":"Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases.Materials and methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes.Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements.Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.","PeriodicalId":23634,"journal":{"name":"Vaccines","volume":"13 1","pages":""},"PeriodicalIF":5.2000,"publicationDate":"2024-12-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11768563/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Vaccines","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3390/vaccines13010006","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The COVID-19 pandemic disrupted routine child immunization efforts, threatening to reverse progress in controlling vaccine-preventable diseases.

Materials and methods: We analyzed the impact of COVID-19 on DTP3 vaccination in Europe by comparing trends before and after the pandemic using time series data from 2000 to 2023. Employing joinpoint regression, chi-square tests, and segmented regression analysis, we assessed DTP3 vaccination trends and coverage changes.

Results: The findings revealed significant regional disparities across Europe. Statistical models indicated reductions in DTP3 coverage in countries such as Ireland, Sweden, and Switzerland, whereas Ukraine and San Marino showed improvements.

Conclusions: There are variations in the effect of COVID-19 on DTP3 coverage rates, indicating the need for targeted public health strategies to address vaccine hesitancy, logistical barriers, and systemic inequities.

查看原文本刊更多论文

求助全文

约1分钟内获得全文求助全文

来源期刊

Vaccines Pharmacology, Toxicology and Pharmaceutics-Pharmacology

CiteScore

8.90

自引率

16.70%

发文量

1853

审稿时长

18.06 days

期刊介绍： Vaccines (ISSN 2076-393X) is an international, peer-reviewed open access journal focused on laboratory and clinical vaccine research, utilization and immunization. Vaccines publishes high quality reviews, regular research papers, communications and case reports.